Access count of this item: 238

Files in This Item:
File Description SizeFormat 
ni.2749.pdf2.36 MBAdobe PDFView/Open
Title: Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity.
Authors: Hara, Hideki  KAKEN_id
Tsuchiya, Kohsuke  KAKEN_id
Kawamura, Ikuo  kyouindb  KAKEN_id
Fang, Rendong
Hernandez-Cuellar, Eduardo
Shen, Yanna
Mizuguchi, Junichiro
Schweighoffer, Edina
Tybulewicz, Victor
Mitsuyama, Masao
Author's alias: 原, 英樹
土屋, 晃介
河村, 伊久雄
光山, 正雄
Issue Date: 3-Nov-2013
Publisher: Nature Publishing Group
Journal title: Nature immunology
Volume: 14
Issue: 12
Start page: 1247
End page: 1255
Abstract: The inflammasome adaptor ASC contributes to innate immunity through the activation of caspase-1. Here we found that signaling pathways dependent on the kinases Syk and Jnk were required for the activation of caspase-1 via the ASC-dependent inflammasomes NLRP3 and AIM2. Inhibition of Syk or Jnk abolished the formation of ASC specks without affecting the interaction of ASC with NLRP3. ASC was phosphorylated during inflammasome activation in a Syk- and Jnk-dependent manner, which suggested that Syk and Jnk are upstream of ASC phosphorylation. Moreover, phosphorylation of Tyr144 in mouse ASC was critical for speck formation and caspase-1 activation. Our results suggest that phosphorylation of ASC controls inflammasome activity through the formation of ASC specks.
Description: 炎症応答を制御する新たな仕組みを解明 -慢性炎症や自己炎症性疾患の病態理解に貢献-. 京都大学プレスリリース. 2013-11-04.
Rights: © 2013 Nature Publishing Group.
許諾条件により本文は2014-05-04に公開.
この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。This is not the published version. Please cite only the published version.
URI: http://hdl.handle.net/2433/179525
DOI(Published Version): 10.1038/ni.2749
PubMed ID: 24185614
Related Link: http://www.kyoto-u.ac.jp/ja/news_data/h/h1/news6/2013_1/131104_1.htm
Appears in Collections:Journal Articles

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.